Sree Rayalaseema Hypo Q2FY27: consolidated PAT +40% YoY, revenue +35%, margins expand
PAT +40.39% YoY · revenue +35.11% · margins expanding
₹246.41 Cr
+35.11% YoY
₹32.7 Cr
+40.39% YoY
12.74%
+0.5pp YoY
₹19.18
Consolidated PAT for the quarter ended September 30, 2026 rose 40% YoY to ₹32.70 Cr (owners' share ₹32.92 Cr) on revenue from operations of ₹246.41 Cr, up 35% YoY and 17% QoQ. The quarter carries a small ₹1.11 Cr exceptional gain booked on gold futures, versus nil in the year-ago quarter; stripping it out, adjusted YoY PAT growth works out to roughly 36% (adjusted PAT ≈ ₹31.6 Cr) against the 40% reported, so the underlying print is only modestly softer than the headline. Standalone PAT of ₹33.13 Cr sits within 2% of the consolidated number, so the choice of basis doesn't change the read.
Q2 FY-2027 vs prior quarters
Net profit margin expanded to 12.74% from 12.29% a year ago and 11.20% last quarter, but the improvement leans more on a 43% YoY jump in other income (₹10.17 Cr vs ₹7.10 Cr) and a lower effective tax rate (25.9% vs 26.8% YoY) than on core operations: the operating margin (profit before exceptional items/tax, adjusted for other income, finance cost and depreciation, as a % of revenue from operations) was roughly flat-to-down YoY at ~14.3% against 14.8% in Q2 FY26, even as it ticked up slightly from ~14.2% in Q1 FY27. Cost of materials consumed, the largest expense line, rose broadly in step with revenue (₹133.20 Cr vs ₹89.95 Cr YoY), consistent with volume-led rather than margin-led topline growth.
The stock went into the print at ₹517, down 6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
There is no published analyst coverage or consensus estimate for this stock this quarter, so vsStreet is unknown rather than a miss; management has also issued no formal guidance on record to grade the print against, and no press release or commentary accompanied the regulatory filing beyond the standard board-outcome letter. The quarter's other corporate developments — the trading-window closure ahead of results, the special window for physical share transfers, and K Phaneendra Rao's induction as an independent director following another director's completed tenure — are governance and administrative matters that don't bear on the chemicals/wind-power operating numbers reported here.
W1
Whether other income (₹10.17 Cr this quarter, +43% YoY) normalizes next quarter — it's the main driver of the NPM gain over the flatter OPM.
W2
Core operating margin trajectory — OPM was flat-to-down YoY (~14.3% vs 14.8%); watch if cost of materials (₹133.2 Cr, up with revenue) keeps pace with or outpaces sales next quarter.
W3
H1 FY27 PAT already at ~64% of FY26's full year (₹90.15 Cr) — whether H2 sustains this run-rate to beat the full-year FY26 PAT.